Asian Journal of Immunology

Gender Difference in the Proliferation Rate of Human Umbilical Cord-derived Mesenchymal Stem Cells

Junbei Xiang

Sichuan Vocational College of Nursing, China.

Qian Wan *

Chengdu Neo-life Hope Medical Testing Lab. Co. Ltd, Chengdu 610036, China.

Xiao Xiao

Chengdu Neo-life Hope Medical Testing Lab. Co. Ltd, Chengdu 610036, China.

*Author to whom correspondence should be addressed.

---

Abstract

Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) are gaining increasing attention by the clinician and basic researchers, because of their specific advantages. But, the gender difference of hUC-MSCs is usually neglected, which is not beneficial to the delicate operations using hUC-MSCs. This research originated from the finding during the routine research involving for hUC-MSCs and aimed to investigate the proliferation rate difference between the male and the female hUC-MSCs systematically. In this research, under the same conditions, the consecutive 14 batches of the male and the female hUC-MSCs were prepared and identified. Then, the proliferation rates of these cells were measured and analyzed statistically. Finally, the transcriptional expression patterns for the 12 proliferation-related genes were representatively analyzed by quantitative PCR (qPCR). The results showed, under the same preparative conditions, the male hUC-MSCs proliferated faster that the female counterpart significantly; meanwhile, for the transcriptional expression levels for most of the 12 proliferation-related genes, the male was higher than the female. This research was the first report to investigate the proliferation rate difference between the male and female hUC-MSCs and preliminarily clarify the possible mechanism, which expanded the understanding for hUC-MSCs.

Keywords: Quantitative PCR, transcriptional expression, mesenchymal stem cells, hUC-MSCs

---

---

---

References

Suzuki G. Translational research of adult stem cell therapy. World J Cardiol. 2015; 7(11):707-718.

Konala VB, Mamidi MK, Bhonde R, Das AK, Pochampally R, Pal R. The current landscape of mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration. Cytotherapy. 2015;pii: S1465-3249(15)01101-1109.

Pers YM, Ruiz M, Noël D, Jorgensen C. Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthritis Cartilage. 2015;23(11):2027-2035.

Kobolak J, Dinnyes A, Memic A, Khademhosseini A, Mobasheri A. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods. 2015, pii: S1046-2023(15)30092-X.

Vangsness CT Jr, Sternberg H, Harris L. Umbilical Cord Tissue Offers the Greatest Number of Harvestable Mesenchymal Stem Cells for Research and Clinical Application: A Literature Review of Different Harvest Sites. Arthroscopy. 2015;31(9):1836-1843.

Sypecka J, Sarnowska A. Mesenchymal cells of umbilical cord and umbilical cord blood as a source of human oligodendrocyte progenitors. Life Sci. 2015; 139:24-29.

Whitfield ML, George LK, Grant GD, Perou CM. Common markers of proliferation. Nat Rev Cancer. 2006;6(2):99-106.

Shamsul BS, Aminuddin BS, Ng MH, Ruszymah BH. Age and gender effect on the growth of bone marrow stromal cells in vitro. Med J Malaysia. 2004;59 Suppl B:196-197.

Zanotti S, Kalajzic I, Aguila HL, Canalis E. Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells. PLoS One. 2014;9(1):e86757.

Hong L, Sultana H, Paulius K, Zhang G. Steroid regulation of proliferation and osteogenic differentiation of bone marrow stromal cells: a gender difference. J Steroid Biochem Mol Biol. 2009;114(3-5):180-185.